View in EDS

Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.

Saved in:
Bibliographic Details
Title: Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Authors: Pasalic D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McGinnis GJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fuller CD; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grossberg AJ; Oregon Health & Science University, Portland, OR, USA., Verma V; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Mainwaring W; Baylor College of Medicine, Houston, TX, USA., Miller AB; The University of Texas Health Science Center, McGovern Medical School, Houston, TX, USA., Lin TA; The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Jethanandani A; The University of Tennessee Health Science Center, Memphis, TN, USA., Espinoza AF; Baylor College of Medicine, Houston, TX, USA., Diefenhardt M; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany., Das P; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah V; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah IM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jagsi R; University of Michigan, Ann Arbor, MI, USA., Garden AS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fokas E; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Frankfurt, Germany., Rödel C; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Frankfurt, Germany., Thomas CR Jr; Oregon Health & Science University, Portland, OR, USA., Minsky BD; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ludmir EB; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ebludmir@mdanderson.org.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Sep; Vol. 136, pp. 176-185. Date of Electronic Publication: 2020 Jul 20.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32702645
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pasalic+D%22">Pasalic D</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22McGinnis+GJ%22">McGinnis GJ</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Fuller+CD%22">Fuller CD</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Grossberg+AJ%22">Grossberg AJ</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Verma+V%22">Verma V</searchLink>; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mainwaring+W%22">Mainwaring W</searchLink>; Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Miller+AB%22">Miller AB</searchLink>; The University of Texas Health Science Center, McGovern Medical School, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lin+TA%22">Lin TA</searchLink>; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Jethanandani+A%22">Jethanandani A</searchLink>; The University of Tennessee Health Science Center, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Espinoza+AF%22">Espinoza AF</searchLink>; Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Diefenhardt+M%22">Diefenhardt M</searchLink>; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Das+P%22">Das P</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+V%22">Subbiah V</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+IM%22">Subbiah IM</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jagsi+R%22">Jagsi R</searchLink>; University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Garden+AS%22">Garden AS</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Fokas+E%22">Fokas E</searchLink>; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Rödel+C%22">Rödel C</searchLink>; University of Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Frankfurt, Germany; German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Thomas+CR+Jr%22">Thomas CR Jr</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Minsky+BD%22">Minsky BD</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ludmir+EB%22">Ludmir EB</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ebludmir@mdanderson.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2020 Sep; Vol. 136, pp. 176-185. <i>Date of Electronic Publication: </i>2020 Jul 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32702645
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2020.06.015
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 176
    Titles:
      – TitleFull: Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pasalic D
      – PersonEntity:
          Name:
            NameFull: McGinnis GJ
      – PersonEntity:
          Name:
            NameFull: Fuller CD
      – PersonEntity:
          Name:
            NameFull: Grossberg AJ
      – PersonEntity:
          Name:
            NameFull: Verma V
      – PersonEntity:
          Name:
            NameFull: Mainwaring W
      – PersonEntity:
          Name:
            NameFull: Miller AB
      – PersonEntity:
          Name:
            NameFull: Lin TA
      – PersonEntity:
          Name:
            NameFull: Jethanandani A
      – PersonEntity:
          Name:
            NameFull: Espinoza AF
      – PersonEntity:
          Name:
            NameFull: Diefenhardt M
      – PersonEntity:
          Name:
            NameFull: Das P
      – PersonEntity:
          Name:
            NameFull: Subbiah V
      – PersonEntity:
          Name:
            NameFull: Subbiah IM
      – PersonEntity:
          Name:
            NameFull: Jagsi R
      – PersonEntity:
          Name:
            NameFull: Garden AS
      – PersonEntity:
          Name:
            NameFull: Fokas E
      – PersonEntity:
          Name:
            NameFull: Rödel C
      – PersonEntity:
          Name:
            NameFull: Thomas CR Jr
      – PersonEntity:
          Name:
            NameFull: Minsky BD
      – PersonEntity:
          Name:
            NameFull: Ludmir EB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2020 Sep
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 136
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1